Testing effectiveness (Phase 2)Study completedNCT01023516
What this trial is testing
Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/Formoterol
Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 615